Design and synthesis of peptides from Phoneutria nigriventer δ-ctenitoxin-Pn2a for antivenom production
; Birocco, Ariadna María ; Blachman, Agustin ; Calabrese, Graciela Cristina ; Acosta, Gerardo ; Albericio Palomera, Fernando ; Camperi, Silvia Andrea 
Otros responsables
Fecha
03/2023
Editorial
Springer
Revista
International Journal Of Peptide Research And Therapeutics
Título del libro
Nombre del evento
Fecha del evento
Institución organizadora
ISSN
1573-3149
eISSN
ISBN
Idioma
Inglés
Tipo del evento
Clasificación temática
Palabras clave
Resumen
The venom toxin δ-ctenitoxin-Pn2a of the spider Phoneutria nigriventer can cause severe envenomation in humans. Furthermore, the cystine-knot motif of δ-ctenitoxin-Pn2a provides exceptional stability, thereby hampering immune response activation. Here we identified epitope G34YFWIAWYKLANCKK48 from δ-ctenitoxin-Pn2a through the Immune Epitope Database Analysis Resource and used it to design antigenic peptides. The Cys residue was replaced by α-aminobutyric acid (Abu) to prevent disulfide bond formation. To increase the immunogenicity of these molecules, branched and N-palmitoylated versions were synthesized. Ac-GYFWIAWYKLAN-Abu-KKG-NH2 (A), Palm-GYFWIAWYKLAN-Abu-KKG-NH2 (B) and (Ac-GYFWIAWYKLAN-Abu-KK)2-KG-NH2 (C) were prepared by solid-phase synthesis and their identity was confirmed by ESI–MS. They were then studied by RP-HPLC and all the chromatograms obtained showed only one main peak. Cytotoxicity was evaluated on the murine macrophage cell line RAW 264.7 using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay in the presence of increasing doses of each peptide (0.25–10.0 µM). Peptide A did not show cytotoxicity between 0.25 and 10.0 µM, while B and C did at concentrations equal or over 0.5 and 10.0 respectively. The cellular distribution of NF-κB was examined by immunofluorescence after exposing macrophages to 0.5 µM of each peptide. Early activation was observed for all three peptides, thereby indicating that they are promising immunogens for antivenom production. Nevertheless, in vivo tests are still required to assess their immunogenic capacity and whether the antibodies generated can confer protection against the venom.
Aprobación
Revisión
Complementado por
Referenciado por
Licencia Creative Commons
Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa
